Tracking how politics and policy influence health care and medicine. To get the latest delivered to your inbox, sign up for our free D.C. Diagnosis newsletter. And subscribe to STAT+ for inside intelligence on the intersection of Capitol Hill and the life sciences.
The FDA will require strong warnings on labels of certain prescription painkillers and anxiety medications about the overdose risk from combining the drugs.
Read The Story
advertisement
